Member Info for GreenEyes1

I have one hope for the final results RNS and that is that confirms some additional chunky orders for the contract manufacturing (i.e. the preliminary PO of 100K progressing to full on supply). That is the sort of thing that wouldn't necessarily warrant it's own RNS but would be included as an update in a final results RNS. That, for me, would underpin the current valuation, provided they maintain the hope that some of their technology can be successfully monetised.

Until then I too am nervous, not helped by what looks like a lack of buyers and increased selling. I can remember Bill Brown expressing frustration at how slowly the industry moves.

Lol, you haven't needed to hurry to avoid missing out on this one, although final results due any day.

It needs to demonstrate tangible progress, and if it does, wow, 12p here we come! I hope a progress to date narrative accompanies the final results and it reports a juicy contract for Contract Manufacturing. I would be delighted to see this find a new support at 20-25p after final results but all very dependent on positive developments.

Any significant progress from valves or grafts I expect will be in an RNS of their own and later in the year or even 2025. I think progress on grafts is more likely to come once they have started to generate some more income in the other businesses. Positive progress here would really change the sentiment around the business.

Still a long way to go for RUA but hopefully it's through the 'trough'

I can take the disappointment of England getting dumped out of the Euros, the disappointment of RUA taking a piddly 15M buyout would be a step too far. The Irony of turning to a Scotsman for salvation LOL.

If you are rewarded for patience, then RUA investors must be in for a good time. Last year final results were in the final week of July on a Wednesday (when it was obvious they were going to report that they didn't have the money to see out another year), the three prior to that were on the second Monday of July.

I'm incredibly anxious for a report that will probably tell me nothing I don't already know, except for any narrative on the first quarter of the new year.

It seems nobody is topping up until more is known, wish I knew why sellers are selling at this point, having waited this long its seems slightly mad (I hope).

Apologies for the bored post!

Just for balance, what are the chances of seeing 7p after the results? Gulp.

Absolutely Intra. And with RUAs current SP the merest of green shoots could yield the most disproportionate change in SP. Or not, of course! Maybe the only prediction I can make with any accuracy is that we will get an RNS this month! I wait to be humiliated.

Lol, the 'new strategy' RNS which was something and nothing sent the shares to about 38p, all I know is it could go anywhere at any time, the low price is mostly based on scepticism on what they can achieve. An actual bit of good news instead of hopes will change that. I'm remain a keen investor because the best case scenario will be an outrageous gain but a good start would be to land a large contract manufacturing order.

Thanks

I'm choosing to remain nonchalant, I recall the CFO purchasing shares at 50p right before the collapse, normally that would be taken as a good sign!

That said, I'm still of the opinion they are expecting some good news which is what is delaying them announcing the Final Results (believing they want to include an update in the RNS). To my knowledge they have an obligation to formally announce the Final Results.

Musing is all we can do for now!

Would someone mind clarifying for me as I am unsure, if these options were taken in full does that amount to dilution of the existing shares issued, or are these option shares held by the business already?

20p after good news might be optimistic - but this does depend on the news! if contract manufacturing lands a big contract before news on valves or grafts I can see up to 30M MCap. I'm torn, but I have manageable position at this level to hopefully aid a quick exit or to minimise dilution at a new level.

I'll bow down to your technical knowledge on that Jimzi, I may be confusing terminology, I was referencing the number of sellers who I believe would exit on a small gain very quickly given the number of shares held that would double in value at 22p. There's been a couple of weighty sells this morning.

IntraVnus - I agree. I have a theory that RUA are withholding notifying about final results in anticipation of including some good news (which they must be expecting if I am right). And if it is a 'blow the doors off' RNS as CTSFO (and the rest of us) hopes we might need to take our socks off to count the multiplications of the SP - except that as you point out the overhang is huge and many of them would probably take a doubling of the SP without a second thought.

CTSFO - if you find the time it is worth going back to 2019 /18 and following the story through RUA updates, the first error came when due to Covid the additional cleaning in the lab actually contaminated a crucial test they carried out (grafts) and delayed proceeding by about six months. Ever since then we have been waiting for that transformational RNS but things went from bad to worse, a lot of the spoils of the tech (if it ever gets to market) is now going have to be shared to get the various products over the line.

Ultimately I believe the reward (which comes with equal risk) will be huge which is why I keep a position here.

Tomorrow marks the latest RUA notify the markets of final year results in recent years.

So I'm going to put a positive spin on and say they are waiting for something cheerful to report with it (as they seem to like to do) and that they would only hold off if they were expecting something to report.

Of course that could be fantasy rather than reality but I'm an optimist!

Might as well chuck in my pennies worth...

Only my opinion.

There was a year end trading update released early June last year, so I am expecting similar this year. The SP can jump on the most meagre of positive statements, although they tend to fall back fairly quick. Final results are released late July, these are important as they will provide more information on how long the cash will last (the assumption on here being 3+ years).

Any developments in HV, grafts or Contract Manufacturing will be reported timely when they happen in a dedicated RNS - there's no telling when that could happen.

Despite the expectation of HV testing taking 6 months, realistically, that could take way, way longer. And if the major likes it who knows what the benefit to RUA will be, a small licensing contract or an IP purchase - your guess is as good as mine.

Grafts - I think they could be gently mothballing this rather than actively seeking a partner. If it is a good as they say it is then a six million investment should have suitors fighting each other for it. The lack of interest has me thinking it is risky.

For me the most important development and the best hope in the short term is securing a significant contract manufacturing contract for which they have charged a 'global enterprise' £100K for initial development work. The cost of 'initial development' work makes me think it is for RUA to lose. This alone would more than double the SP. This is important because it could make the business profitable and make the cash position less relevant which is a stronger position for negotiating with partners (it also means they may be able to fund grafts to some degree themselves). It would stop any sharks circling too.

The SP assuming positive developments in HV and grafts depend entirely on the benefit to RUA. The sky's the limit if the tech is a good as they say (if it was, it wouldn't take this long).

The SP is where it is because the risk is so high, this is no longer 'when not if' as Caroline Stratton frequently stated, it is definitely 'if not when'.

Yes, I am invested, far less than in the past and at a loss here. The risk and the reward are high! Capital definitely at risk!

All just my own thoughts and opinions!

Bradshaw Asset Management is the only stand out one, 2.5M in shares (4.12%), or over a quarter of the companies invested funds (March 2023 figure). I think Mark Bradshaw is an ex-city trader gone solo. Hopefully he knows something we don't!

The only other significant interest declaration was Rathbones but how that is split between clients we don't know - there appears to be three. https://polaris.brighterir.com/public/aortech/news/rns/story/w3p8gjx

Https://rualifesciences.com/investor-relations/significant-shareholders/

Were all those buys one entity, or did a group of buyers all steam in, and then stop, in the same short time frame! a curious coincidence if they did. Surely one buyer would spread their buys a bit!

Anyway, can somebody do some selling, I don't want to top up at 13p. 2-3 weeks at most before an RNS lands. Will it stick to final accounts or will it include an update, or will it be preceded altogether with an announcement.

It is implausible that anyone one of a number of people with insider knowledge at either the customer (valves and contract manufacturing) / RUA or a potential partner (grafts) is NOT tipping the wink to extended family / friends. The big buys doesn't mean news is coming or coming imminently, but it it certainly creates a strong suspicion that some major positive breakthrough has occurred. Remember with RUA, a few big buys is all it takes, and a whole load of small investors start jumping onboard to top up, so it could also just be a false start. What it does indicate is there are a lot of buyers for when/if news does drop.

Looking at trades (I don't pay much attention) there seems to be more large purchases than normal. Looking positive.